NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 42 filers reported holding NABRIVA THERAPEUTICS PLC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $750,000 | -19.6% | 1,407,893 | +1.8% | 0.02% | -26.5% |
| Q2 2020 | $933,000 | +526.2% | 1,383,192 | +434.2% | 0.03% | +325.0% |
| Q1 2020 | $149,000 | -57.7% | 258,916 | -2.8% | 0.01% | -50.0% |
| Q4 2019 | $352,000 | -25.4% | 266,384 | +12.9% | 0.02% | -38.5% |
| Q3 2019 | $472,000 | -16.2% | 235,875 | +1.8% | 0.03% | -7.1% |
| Q2 2019 | $563,000 | -0.4% | 231,754 | +0.2% | 0.03% | -6.7% |
| Q1 2019 | $565,000 | +59.6% | 231,373 | -4.6% | 0.03% | +20.0% |
| Q4 2018 | $354,000 | -47.0% | 242,582 | -1.9% | 0.02% | -30.6% |
| Q3 2018 | $668,000 | – | 247,276 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 4,256,526 | $11,493,000 | 2.10% |
| Vivo Capital, LLC | 6,619,190 | $17,872,000 | 1.80% |
| Novo Holdings A/S | 4,703,720 | $12,700,000 | 1.01% |
| Rock Springs Capital Management LP | 1,800,000 | $4,860,000 | 0.18% |
| Orbimed Advisors | 4,644,600 | $12,540,000 | 0.15% |
| Clear Harbor Asset Management, LLC | 212,500 | $443,000 | 0.09% |
| Granahan Investment Management | 247,276 | $668,000 | 0.04% |
| WEDBUSH SECURITIES INC | 92,050 | $249,000 | 0.03% |
| Laurion Capital Management LP | 419,670 | $1,133,000 | 0.01% |
| SECTORAL ASSET MANAGEMENT INC | 38,255 | $103,000 | 0.01% |